Nicola Goekbuget
Department of Medicine, Hematology and Oncology, Goethe University Frankfurt, Frankfurt, Germany · GMALL-Study-Group · Johann Wolfgang Goethe University Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Nicola Goekbuget as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:29 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06648889 · Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic LeukemiaGoethe University · recruiting · T-ALL · study director
- Ph2NCT06061094 · Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCTGoethe University · recruiting · Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia · principal investigator
- Ph1/Ph2NCT05182385 · Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)Goethe University · active not recruiting · ALL, Recurrent, Adult · principal investigator
- Ph2NCT03480438 · Treatment of Older Patients With B-precursor ALL With Sequential Dose Reduced Chemotherapy and BlinatumomabGoethe University · completed · B-Precursor ALL · study director
- Ph2NCT03109093 · Blinatumomab in Adult Patients With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic LeukemiaGoethe University · completed · ALL, Recurrent, Adult · principal investigator
- Ph4NCT00199082 · Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in AdultsNicola Goekbuget · completed · Burkitt's Lymphoma, Burkitt's Leukemia, Mediastinal Neoplasms · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:29 UTC. The ranking covers the 200 most relevant of 3 PubMed records, and a shared surname and initials can bring in a namesake. All 3 on PubMed